Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: A multi-institutional study

Annals of Surgical Oncology

Volumn 13, Issue 6, 2006, Pages 809-816

  Wong, Sandra L ^a   Morton, Donald L ^b   Thompson, John F ^c   Gershenwald, Jeffrey E ^d   Leong, Stanley P L ^e   Reintgen, Douglas S ^f   Gutman, Haim ^g   Sabel, Michael S ^h   Carlson, Grant W ⁱ   McMasters, Kelly M ^j   Tyler, Douglas S ^k   Goydos, James S ^l   Eggermont, Alexander M M ^m   Nieweg, Omgo E ⁿ   Cosimi, A Benedict ^o   Riker, Adam I ^p   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Lakeland Regional Cancer Center   (United States)

^g TEL AVIV UNIVERSITY   (Israel)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j University of Louisville School of Medicine   (United States)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

Completion lymphadenectomy; Melanoma; Recurrence; Sentinel lymph node biopsy; Survival

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPLETION LYMPH NODE DISSECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

COHORT STUDIES; EXTREMITIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33646560013     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.03.058     Document Type: Article

References (15)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-9.
2. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-83.
3. McMasters KM, Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002; 9:137-41.
4. Reeves ME, Delgado R, Busam KJ, et al. Prediction of non-sentinel lymph node status in melanoma. Ann Surg Oncol 2003; 10:27-31.
5. Sabel MS, Gibbs JF, Cheney R, et al. Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center. Surgery 2000; 128:556-63.
6. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91:2110-21.
7. Gershenwald JE, Berman RS, Porter G, et al. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 2000; 7:226-31.
8. Pidhorecky I, Lee RJ, Proulx G, et al. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol 2001; 8:109-15.
9. Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002; 184:520-4; discussion 525.
10. Lee RJ, Gibbs JF, Proulx GM, et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000; 46:467-74.
11. Clary BM, Mann B, Brady MS, et al. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 2001; 8:328-37.
12. Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999; 6:442-9.
13. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16:2253-60.
14. Weijer C, Shapiro SH, Cranley Glass K. For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. BMJ 2000; 321:756-8.
15. Reintgen D, Pendas S, Jakub J, et al. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol 2004; 31:363-73.